EBM Eastwood Bio-Medical Canada Inc.

TSXV · CA · Financial Services · Biotechnology · eleotin.ca

1.980CAD-1.00%Mkt Cap: 100.33M $P/E: —Today

Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural…

Industry Peers

Biotechnology

Screen all

VRTX

Vertex Pharmaceuticals Incorporated - Common Stock

$127.85BUSDP/E 29.4

MRNA

Moderna, Inc. - Common Stock

$75.86BUSD

REGN

Regeneron Pharmaceuticals, Inc. - Common Stock

$75.69BUSDP/E 18.2

ARGX

argenx SE - American Depositary Shares

Revolution Medicines, Inc. - Common Stock

BeOne Medicines Ltd. - American Depositary Shares

$40.51BUSDP/E 63.9

RPRX

Royalty Pharma plc - Class A Ordinary Shares

$33.03BUSDP/E 30.7

ALNY

Alnylam Pharmaceuticals, Inc. - Common Stock

$29.40BUSDP/E 38.3

ROIV

Roivant Sciences Ltd. - Common Shares

$25.80BUSD

BNTX

BioNTech SE - American Depositary Shares

$24.34BUSD

INSM

Insmed Incorporated - Common Stock

$24.27BUSD

INCY

Incyte Corporation - Common Stock

Genmab A/S - American Depositary Shares

$21.69BUSDP/E 27.4

JAZZ

Jazz Pharmaceuticals plc - Ordinary Shares

$15.30BUSDP/E 16.1

ASND

Ascendis Pharma A/S - Ordinary Share

$14.99BUSDP/E 17.8

EXEL

Exelixis, Inc. - Common Stock

$14.47BUSDP/E 18.4

SMMT

Summit Therapeutics Inc. - Common Stock

$13.37BUSD

Key Statistics

Company

Market Cap100.33M USD

Enterprise Value100.38M USD

Revenue (TTM)591.43K USD

Gross Profit401.27K USD

Net Income (TTM)-242.34K USD

Revenue/Share0.01 CAD

Last Price1.980 CAD

Fiscal Year EndOct 2025

MR QuarterJul 2026

Employees—

CountryCA

SectorFinancial Services

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-934.27

EV/Revenue169.72

P/S169.65

P/B-76.92

EPS (TTM)-0.02

EPS (Forward)—

52W Range

0.345095% of range2.060

52W High2.060 CAD

52W Low0.3450 CAD

Profitability

Gross Margin70.45%

Oper. Margin-41.41%

EBITDA Margin-18.17%

Profit Margin-42.55%

ROE20.42%

ROA-152.11%

Growth

Revenue Growth19.40%

Earnings Growth—

Cash Flow & Leverage

Operating CF14.06K USD

CapEx (TTM)—

FCF Margin12.72%

FCF Yield0.07%

Net Debt43.78K USD

Net Debt/EBITDA-0.41

Balance Sheet

Debt/Equity-0.05

Current Ratio0.05

Quick Ratio0.05

Book Value/Sh-0.03 CAD

Cash/Share0.00 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 CAD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.68.89M

Float21.16M

Insiders69.31%

Institutions0.00%

Short Interest

Short Ratio0.3d

Short % Out.0.01%

Shares Short3.92K

Short (prev mo.)18.56K

Technical

SMA 501.640 (+20.7%)

SMA 2001.001 (+97.8%)

Beta0.35

S&P 52W Chg14.58%

Avg Vol (30d)11.89K

Avg Vol (10d)8.23K

Technical Indicators

RSI (14)72.0

MACD0.0909

MACD Signal0.1002

MACD Hist.-0.0093

BB Upper1.960 CAD

BB Middle1.853 CAD

BB Lower1.746 CAD

BB Width11.60%

ATR (14)0.0885 CAD

Vol Ratio (20d)0.23x